FDA Inspection 1060729 — Yiling Pharmaceutical Ltd.
The FDA completed an inspection of Yiling Pharmaceutical Ltd. on Jun 15, 2018 in Shijiazhuang. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI)
- End Date
- Jun 15, 2018
- Fiscal Year
- 2018
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Shijiazhuang (China)